Site icon Market Globalist

Is that why Kubient, Inc. (KBNT) shares saw a decline before the market kick-off

CYTO Stock

CYTO Stock

Kubient, Inc. (NYSE: KBNT), shares moved -15.81 to $5.6 in the pre-market session, a ‎provider of cloud-based software services for digital advertising downwards, announced ‎today the pricing of its underwritten public Offering of 3,921,411 common shares at $5.10 ‎per share. Net proceeds after underwriting discounts and estimated offering expenses ‎payable by the company are estimated to be about $16.3 million.‎

Get the hottest stocks to trade every day before the market ‎opens 100% ‎free. Click here now. 

‎The Offering is being managed by Maxim Group LLC and Joseph Gunnar & Co., LLC.‎

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Kubient will use net proceeds from the Offering for product development, working capital, ‎capital expenditures, repayment of the debt, and other general corporate purposes, such as ‎investments in sales and marketing in the United States and abroad. A portion of the ‎proceeds may also be used to acquire complementary companies, brands, or technologies.‎‎

Get the hottest stocks to trade every day before the ‎market opens 100% ‎free. Click here now. 

‎A 45-day option has also ‎been granted to the underwriters to purchase up to an additional 529,411 shares at the ‎public offering price less discounts and commissions. Under customary closing conditions, ‎the Offering should close on or about December 28, 2020.‎

Read More

Exit mobile version